Novel Hematocrit-Controlling Approaches in Polycythemia Vera

The phase 3 INTREPID trial is evaluating sapablursen in phlebotomy-dependent polycythemia vera.

Pankit Vachhani, MD, discusses the importance of hematocrit control in the management of polycythemia vera.

Prithviraj Bose, MD, overviews the ongoing investigation of sapablursen in polycythemia vera.

Prithviraj Bose, MD, discusses the ongoing investigation of sapablursen in polycythemia vera.

Pankit Vachhani, MD, discusses data that have read out for sapablursen in the treatment of patients with polycythemia vera.